A/Prof Andrew Haydon
A/Prof Andrew Haydon is a medical oncologist at Alfred Health.
Associate Professor Andrew Haydon is a full-time Medical Oncologist at the Alfred Hospital, Melbourne having joined the hospital in 2004. He is also an Adjunct Senior Lecturer at the Department of Epidemiology and Preventive Medicine, Monash University and an Honorary Associate and Member of the NHMRC Clinical Trials Centre, School of Public Health, University of Sydney. Andrew completed his PhD at Monash University/Cancer Council Victoria in 2004.
Over the last 15 years, he has been the principle investigator for over 30 international clinical trials that he has run at the Alfred Hospital for patients with Gastro-intestinal cancer and advanced melanoma, with many of these studies leading to major changes in the treatment of these diseases.
Dr Haydon has authored or co-authored over 90 peer reviewed journal publications including publications in The New England Journal of Medicine, Lancet Oncology and JCO, and has given numerous local and international presentations on the management of G.I. cancer and metastatic melanoma.
Professional Associations:
- co-director of the Southern Melbourne Integrated Cancer Service
- co-chair of the Victorian Covid-19 Cancer Network.
Professional Memberships:
- Fellow of the Royal Australasian College of Physicians
- Member of the Medical Oncology Group of Australia (MOGA)
- Member of the American Society of Clinical Oncology (ASCO)
- Australasian Gastro-Intestinal Trials Group.
- Australian and New Zealand Melanoma Trials Group